lumakras
(sotorasib)Amgen Inc
Usage: LUMAKRAS is indicated for treating adults with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) after prior systemic therapy, and for KRAS G12C-mutated metastatic colorectal cancer (mCRC) in combination with panitumumab, following specific chemotherapy treatments.